Top Markets
Coin of the day
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Classement en actions #15351
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Prix de l'action
$6.56
Capitalisation boursière
$357.23M
Changement (1 jour)
-0.84%
Changement (1 an)
-61.68%
Pays
US
Échange Upstream Bio, Inc. (UPB)

Catégorie

Historique du prix de l'action pour Upstream Bio, Inc. (UPB)
Prix de clôture le plus élevé : $6.56 le 2026-09-01

Prix de clôture le plus bas : $24.44 le 2024-10-01
Historique du prix de l'action de Upstream Bio, Inc. de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -45.19%
2025 43.52%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.15 40.18%
US
$1.03K 44.14%
NL
$153.87 538.73%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH